Purchase Order HHSN272201600425P
Award Date 3/14/16
Potential Completion Date 3/13/17
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
- This $95,931 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq High Throughput Sequencer System. The award did not have a set-aside designation. The MiSeq system will be used in NIAID's Laboratory of Immunoregulation and must be fully compatible with Illumina's existing on-site software, kits, and reagents. Illumina has a history of providing...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a one-year comprehensive plan to provide HiSeq 2000, cBOT, and MiSeq systems. The $100,884 contract does not include a set-aside provision. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents that have been utilized across various federal agencies, including the Centers...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for an MISEQ2 automated DNA sequencing system. The $90,882 contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic analysis instruments and reagents, and has previously received awards from federal agencies like the NIH, CDC, USDA, and VA to support genomic...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a $32,754.46 firm fixed price delivery order contract awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract provides Illumina's sequencing systems, reagents, and associated services to support genomic research and diagnostics. No set-aside was used. Illumina has previously received other prime federal contract and subcontract awards from agencies like the NIH,...